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Background: Cytidine and uridine are produced commercially by Bacillus subtilis. The production strains of cytidine
and uridine were both derivatives from mutagenesis. However, the exact metabolic and genetic factors affecting the
productivity remain unknown. Genetic engineering may be a promising approach to identify and confirm these factors.
Results: With the deletion of the cdd and hom genes, and the deregulation of the pyr operon in Bacillus subtilis168, the
engineered strain produced 200.9 mg/L cytidine, 14.9 mg/L uridine and 960.1 mg/L uracil. Then, the overexpressed prs
gene led to a dramatic increase of uridine by 25.9 times along with a modest increase of cytidine. Furthermore, the
overexpressed pyrG gene improved the production of cytidine, uridine and uracil by 259.5%, 11.2% and 68.8%,
respectively. Moreover, the overexpression of the pyrH gene increasesd the yield of cytidine by 40%, along with a
modest augments of uridine and uracil. Lastly, the deletion of the nupC-pdp gene resulted in a doubled production of
uridine up to 1684.6 mg/L, a 14.4% increase of cytidine to 1423 mg/L, and a 99% decrease of uracil to only 14.2 mg/L.
Conclusions: The deregulation of the pyr operon and the overexpression of the prs, pyrG and pyrH genes all contribute
to the accumulation of pyrimidine nucleoside compounds in the medium. Among these factors, the overexpression of
the pyrG and pyrH genes can particularly facilitate the production of cytidine. Meanwhile, the deletion of the nupC-pdp
gene can obviously reduce the production of uracil and simultaneously improve the production of uridine.
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Bacillus subtilis is able to synthesize the uridine 5'-
monophosphate (UMP) de novo. The excess UMP can
be further converted to terminal metabolites (cytidine,
uridine and uracil), which could then be secreted out of
the cell (Figure 1). The pyrimidine nucleotide biosyn-
thetic (pyr) operon of B. subtilis contains 10 genes. The
first gene of the pyr operon encodes a bifunctional pro-
tein PyrR which is the regulator protein for pyr operon
and a uracil phosphoribosyl transferase [1]. The second
gene, pyrP, encodes a uracil permease. The remaining
eight genes encode the six enzymes involved in the de
novo biosynthesis of UMP [2]. The expression of the pyr
operon is regulated by transcriptional attenuation* Correspondence: banrui@tju.edu.cn
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unless otherwise stated.mechanism involving PyrR. The PyrR protein is mainly
activated by UMP and the regulating elements are three
specific binding loops (BL1, BL2 and BL3) on the nas-
cent pyr mRNA. The combination of the PyrR protein
and BLs disrupts the antiterminator, permitting the for-
mation of terminator hairpin and leading to the reduced
expression of the downstream genes [3,4]. The resulting
high intracellular concentration of UMP would strongly
inhibit the transcription of the pyr operon.
In B. subtilis, L-aspartate is the precursor of both
amino acids (lysine, methionine, threonine, and isoleu-
cine) and pyrimidine nucleotide biosynthesis (Figure 1).
The deficiency of homoserine dehydrogenase (encoded
by the hom gene) can prevent the aspartate entering to
the methionine and threonine biosynthesis and improve
the supplement to the de novo biosynthesis of UMP [5].
Phosphoribosyl pyrophosphate (PRPP) is another im-
portant precursor of pyrimidine nucleotide biosynthesisis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The biosynthetic pathway of pyrimidine nucleotide in B. subtilis.
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(PRS) is encoded by the prs gene of the gcaD-prs-ctc op-
eron whose transcription regulation mechanism has
been unknown yet [6]. Improving the expression level of
the prs gene can significantly increase the intracellular
pool of PRPP [7,8].
In B. subtilis, UMP kinase, which is encoded by the
pyrH gene, catalyzes the phosphorylation of UMP by
ATP to yield UDP and ADP (Figure 1). The UMP kinase
activity is regulated allosterically by GTP (activator) and
UTP (inhibitor) [9,10]. The pyrG gene encodes CTP syn-
thetase which aminates UTP to form CTP (Figure 1).
The transcription of the pyrG gene is tightly regulated
by a CTP-sensitive reiterative transcription attenuation
control mechanism [11-13]. The inherent regulation of
the pyrG gene transcription and CTP synthetase activity
limit the excessive synthesis of CTP in B. subtilis.
Catalyzed by non-specific 5′-phosphatase, the exces-
sive intracellular CMP and UMP can be dephosphory-
lated to form cytidine and uridine, respectively. The
cytidine can be further deaminized to form uridine by
cytidine deaminase (encoded by the cdd gene) (Figure 1)
[14]. In the dra-nupC-pdp operon, the pdp gene encodes
pyrimidine nucleoside phosphorylase which catalyzes the
degradation of uridine to form uracil and D-ribose-1-
phosphate [15]. Then, uracil will be secreted out of the
cell. Therefore, the terminal metabolites of pyrimidine
nucleotide are generally uracil instead of cytidine and
uridine in the wild-type B. subtilis. The dra gene
encodes deoxyriboaldolase and the nupC gene encodes
the transporter responsible for pyrimidine nucleosideuptake. The expression of the dra-nupC-pdp operon is
repressed by glucose and induced by deoxyribonucleo-
sides and deoxyribose [16,17]. When the carbon source
is poor, by the physiological function of the dra-nupC-
pdp operon, the pyrimidine nucleoside accumulated in
the medium could be recycled as carbon source. Obvi-
ously, the physiological functions of nupC and pdp genes
make no contribution to the accumulation of pyrimidine
nucleoside in the medium.
B. subtilis strains with defect and pyrimidine analogue
resistant could accumulate large amounts of cytidine or
uridine [18-21]. Nevertheless, the exact genetic and
metabolic mechanisms resulting in pyrimidine nucleo-
side over-production have not been fully identified and
confirmed.
In this study, by using genetic manipulation method,
we modified some key genes and operons related to the
pyrimidine nucleotide biosynthesis in B. subtilis 168 and
investigated the influence of these modifications on the
production of pyrimidine nucleoside compounds.
Results
Deletion of the cdd and hom genes
In order to observe the effects of the related genetic
modification on cytidine and uridine synthesis separ-
ately, we blocked the reaction from cytidine to uridine
by deleting 151 bp coding sequences of the cdd gene in
B. subtilis 168 N and obtained the cdd gene deficient
strain B. subtilis TD01 (Additional file 1: Figure S1).
Subsequently, in order to improve the supplement of as-
partate for the pyrimidine nucleotide biosynthesis, we
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strain TD01 and obtained the strain B. subtilis TD02
(Additional file 1: Figure S2). The shake-flask culture ex-
periments demonstrated that the strain TD02 could ac-
cumulate cytidine and uracil in detectable level in
medium while no uridine was detected (Figure 2).
Deregulation of the pyr operon
As described before, the transcription regulation mech-
anism of the pyr operon restricted the over-synthesis of
UMP and its derivatives. We deleted 738 bp coding se-
quences of the pyrR gene in the strain TD02 and con-
structed the recombinant B. subtilis TD12 (Additional
file 1: Figure S3). The pyr operon mRNA transcription
level in the ΔpyrR strain TD12 was compared with par-
ent strain TD02 through RT-qPCR analysis. We chose
the sequences which lay in the middle of the pyr operon
as the detective point. The transcript abundance in-
creased 6.28-fold in TD12 (Figure 3), which indicated
that the pyr operon was deregulated in ΔpyrR strain.
The shake-flask culture experiments showed that the
strain TD12 could accumulate 200.9 ± 8.3 mg/L cytidine,
14.9 ± 0.8 mg/L uridine and 960.1 ± 39.1 mg/L uracil, re-
spectively (Figure 2). The deregulation of the pyr operon
expression could significantly increase the accumulation
of both cytidine and uracil, and have little effect on the
accumulation of uridine in the medium.
Overexpression of the prs gene
PRPP is not only a precursor for UMP de novo biosyn-
thesis but also locates in the crossing point in multiple
metabolic pathways. To illustrate the impact of intracel-
lular PRPP level on the biosynthesis of UMP and itsFigure 2 Pyrimidine and pyrimidine nucleoside accumulation by B. subtilis
replicates with error bars indicating standard error from the mean (TD02, Tderivatives, we overexpressed the prs gene in TD12 and
constructed recombinant strain B. subtilis TD13. The
RT-qPCR analyses showed that a 72.86-fold improve-
ment of the prs mRNA transcription level occurred in
recombinant TD13 compared with parental strain TD12,
which indicated that the prs gene was successful overex-
pressed (Figure 3). The flask culture revealed that the re-
combinant strain TD13 accumulated 247.2 ± 9.6 mg/L
cytidine, 440.7 ± 17.1 mg/L uridine and 935.7 ± 31.9 mg/L
uricil in medium, respectively (Figure 2). Compared with
strain TD12, the accumulation of cytidine and uracil of
strain TD13 slightly rose or dropped, but the accumulation
of uridine significantly increased by 25.9-fold. These results
demonstrated that pyrimidine nucleotide precursor can be
further increased by overexpressing the prs gene, and intra-
cellular PRPP level was an important rate-limiting factor in
biosynthesis of UMP and its derivatives. In other words,
the improvement of PRPP supplement could increase the
synthesis of pyrimidine nucleoside which was mainly
reflected in the improvement of uridine.
Overexpression of the pyrG gene
The CTP synthetase (encoded by the pyrG gene) cata-
lyzes the reaction from UTP to CTP. In order to investi-
gate the effects of CTP synthetase level on pyrimidine
nucleoside biosynthesis, we constructed the recombinant
B. subtilis TD231 by introducing 4 extra G residues at
the 5′ ends of the pyrG transcripts based on the strain
TD13 [13]. Meanwhile, on the basis of strain TD13, we
constructed recombinant B. subtilis TD232 by repleacing
the ITR of the pyrG gene with the gsiB mRNA stabilizer
and made the promoter of the pyrG gene consensus
(Figure 4). The RT-qPCR analysis showed that thestrains after 72 h fermentation. Results are the average of three
D12, TD13, TD231, TD232 and TD33).
Figure 3 Relative transcriptional levels of mRNA in the recombinant strains. The mRNA expression levels of WT strain is regarded as 1(blank).
The relative mRNA expression levels of recombinant strains (filled) are compared with WT strain. (A) Relative transcriptional levels of the pyrR gene.
ΔpyrR: the pyrR gene was deleted. (B) Relative transcriptional levels of the prs gene. prs+: the prs gene was overexpressed. (C) Relative transcriptional
levels of the pyrG gene. pyrG+: the pyrG gene was constitutively expressed. pyrG+*: the pyrG gene was overexpressed. (D) Relative transcriptional levels
of the pyrH gene. pyrH+: the pyrH gene was overexpressed. The ccpA gene was used as the internal control gene to normalize the results. Results are
the average of three replications with error bars indicating standard error from the mean.
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and TD232 were about 325-fold and 675-fold, respect-
ively, in comparison to the parent strain TD13 contain-
ing the pyrG gene (Figure 3). In the flask fermentation
medium, the TD231 and TD232 could accumulate 301.3 ±
13.7 mg/L and 888.7 ± 25.7 mg/L cytidine, which achieved
a 21.9% and a 259.5% improvement compared to the pyrG
gene WT strain TD13, respectively (Figure 2). Meanwhile,
the uracil production increased about 33% (1244.9 ±
10.9 mg/L) and 68.8% (1579 ± 49.8 mg/L), respectively,
while the uridine production only increased ~7.9%
(474.6 ± 11.8 mg/L) and ~11.2% (490.1 ± 19.1 mg/L),Figure 4 Nucleotide sequence of PSB expression cassette. The sequence of
promoter, Shine–Dalgarno sequence (SD) and initiation codon are bold anrespectively (Figure 2). These results revealed that the
improvement of CTP synthetase level could not only
contribute to the production of the downstream metab-
olites of CTP (known as cytidine), but also those of
UMP (known as uracil & uridine). This may be ex-
plained by that the improvement of metabolic flux to
cytidine led to the reduction of the intracellular UMP
pool and subsequently the UMP synthesis was released
from UMP-sensitive feedback inhibition to some ex-
tent, so that UMP synthesis increased in actually and a
part of the increased UMP contributed to the elevation
of uridine/uracil production.the nontemplate strand is shown. The −10 and −35 regions of the
d underlined. The RNA-stabilizing elements are shown in italics.
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Among the reactions from UMP to cytidine, UMP kin-
ase (encoded by the pyrH gene) might serve as a rate-
limiting factor. In order to confirm this, we overex-
pressed the pyrH gene in strain TD232 and obtained the
recombinant B. subtilis TD33. The RT-qPCR analyses
showed that the pyrH mRNA level of TD33 was about
3.75-fold higher than that of strain TD232 of which the
pyrH gene was wild-type (Figure 3). The shake flask fer-
mentation experiments showed that the recombinant
TD33 accumulated 1244.2 ± 53.9 mg/L cytidine, 558.6 ±
24.2 mg/L uridine and 1696.7 ± 39.7 mg/L uracil in the
culture broth and increased by 40%, 14% and 7.5%, re-
spectively, compared with strain TD232 (Figure 2). The
production of cytidine, uridine and uracil all increased
with the improvement of UMP kinase express level.
These results proved that UMP kinase express level was
also a rate-determining factor of pyrimidine nucleoside
compounds production.
Disruption of the nupC-pdp gene
To ascertain the effect of the nupC-pdp gene on pyrimi-
dine nucleoside accumulation in B. subtilis, the nupC-
pdp gene was deleted from the chromosome of strains
TD12, TD13 and TD33, respectively (Additional file 1:
Figure S4). The corresponding derivative strains were
named as B. subtilis TD12np, TD13np and TD33np, re-
spectively. The culture broth analyses of the six strains
were shown in Table 1. In the strains (TD13np and
TD33np) with the prs gene overexpressed, the knockout
of the nupC-pdp gene led to a decrease of the uracil
yield by 99% on average, while an increase of cytidine
and uridine yield by 23% and 230% on average, respect-
ively. In strain TD12 (the prs gene is wild-type), the
knockout of the nupC-pdp gene led to a decreased accu-
mulation of uracil by about 50%, while an increased ac-
cumulation of cytidine and uridine by about 0.3-fold and
79-fold, respectively. These results indicated that the ac-
cumulated uracil in medium was mainly derived from
the degradation of uridine catalyzed by pyrimidine
nucleoside phosphorylase. Meanwhile, there may beTable 1 Pyrimidine and pyrimidine nucleoside produced by m
biosynthesis pathway in B. subtilis after 72 h fermentation
Strain Productivity (mg/L) Ratio (%) Productivity (mg/L)
Cytidine Uridine
TD12 200.9 ± 8.3 14.9 ± 0.8
TD12np 260.3 ± 11.3 129.6 1187.5 ± 49.9
TD13 247.2 ± 9.6 440.7 ± 17.1
TD13np 326.9 ± 7.0 132.2 1571.4 ± 38.9
TD33 1244.2 ± 53.9 558.6 ± 24.2
TD33np 1423.0 ± 47.5 114.4 1684.6 ± 62.4
Data shown are the average of three independent experiments.another metabolic reaction remains unknown, which
could generate uracil in B. subtlis, and the rate of the
unknown reaction may be controlled by intracellular
PRPP pool level.
Together with the inactivation of the cdd, hom and
pyrR genes, the deletion of nupC-pdp gene led to a slight
increase of the total amount of pyrimidine compounds
(i.e., cytidine, uridine, and uracil) accumulated in the
culture. However, together with the inactivation of the
cdd, hom and pyrR genes and the overexpression of the
prs gene, the deletion of the nupC-pdp gene led to a
modest decrease of the total amount of pyrimidine com-
pounds in the culture. Nevertheless, if the pyrH and
pyrG genes were both overexpressed subsequently, the
total amount of pyrimidine compounds in the culture
would be doubled to about 22 mmol/L (Table 1). These
results revealed that the overexpression of the pyrH and
pyrG genes caused a metabolic flux enlargement from
UMP to cytidine, thereby, reducing the intracellular
UMP level which may relieve feedback inhibition for
UMP to carbamyl phosphate synthetase and lead to
more UMP synthesis.The growth of recombinant strains
In shaking flask fermentation, we measured the biomass
of the recombinant strains mentioned above. The data
showed that the cell growth of recombinant strains were
similar to that of the parental strains (Figure 5). There-
fore, the above modification of relevant genes of pyrimi-
dine nucleotide biosynthesis had no detectable effect on
cell growth.Discussion
As already shown in the “introduction”, the pyrimidine
nucleotide biosynthesis of B. subtilis was strictly regu-
lated so that no excess pyrimidine nucleoside would be
synthesized and secreted to the medium. In order to well
illuminate the rate-determining factors affecting pyrimi-
dine nucleoside excess synthesis, we chose genetic en-
gineering as a desired strategy.odifying different genes of the pyrimidine nucleotide
Ratio (%) Productivity (mg/L) Ratio (%) Molarity (mmol/L)
Uracil Total
960.1 ± 39.1 9.5
7970 508.2 ± 18.5 52.9 10.5
935.7 ± 31.9 11.2
356.6 16.9 ± 0.1 1.8 7.9
1696.7 ± 39.6 22.6
301.6 14.2 ± 0.2 0.8 22.9
Figure 5 The biomass of recombinant strains in 72 h fermentation.
Data obtained are the result of three independent fermentations.
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from cytidine to uridine and resulted in the accumula-
tion of cytidine in the medium, indicating that the
deficiency of the cdd gene is a key factor of the accumu-
lation of cytidine. The result coincided with the experi-
mental findings of previous studies [22].
Based on the hom and cdd genes deficiency, the de-
regulation of the pyr operon by deleting the pyrR gene
doubled the yield of both cytidine and uracil, while mu-
tagenesis was the mere prevailing method to achieve the
same genetic effect in the past [21]. However, though
one determining factor of UMP biosynthesis have been
revealed with deregulation of the pyr operon, the carba-
moyl phosphate synthetase (encoded by the pyrAA/pyrAB
gene), which catalyzes the first reaction of UMP de novo
biosynthesis, is still subjected to feedback inhibition by
UMP [23,24]. Hence, the excess synthesis of pyrimidine
nucleoside compounds is still considered to be limited.
The overexpression of the prs gene resulted in an in-
crease of uridine yield by 25.9-fold in this work. Analo-
gous experimental results also existed in the study of
biosynthesis of purine nucleoside and its derivatives in B.
subtilis [8,25]. Thus, PRPP pool level is one important re-
strictive factor affecting the overproduction of nucleotide
and its derivatives. However, PRS is an allosteric enzyme
and its activity is intensively feedback inhibited by purine
nucleotide [26]. By using site-directed mutation to release
the feedback inhibition of phosphoribosyl pyrophosphate
synthetase (PRS), satisfactory results may be obtained.
The overexpression of the pyrG and pyrH genes resulted
in a significantly increased amount of cytidine in the
medium, proving that the activity of both UMP kinase
and CTP synthetase were rate-determining factors for
cytidine over-synthesis. Since both UMP kinase and CTP
synthetase are allosteric enzymes, it is believed that by re-
leasing their feedback inhibition, the cytidine productioncould be further improved. The overexpression of the
pyrG and pyrH genes also led to an increase in the total
pyrimidine compounds accumulation in the medium. We
interpret that the augmented metabolic flux from UMP to
CTP could reduce the intracellular UMP level and thereby
release the feedback inhibition on UMP biosynthesis, es-
pecially the activity of carbamyl phosphate synthetase.
The pyrimidine nucleoside phosphorylase (encoded by
the pdp gene) involves in the reaction from uridine to
uracil and the loss of the pdp gene should make cell ac-
cumulate only nucleosides and no uracil in theory
[27,28]. However, according to the experimental results,
by deleting the nupC-pdp gene, we obtained that the
uracil accumulation reduced by 99% rather than 100%.
The small amount of uracil remaining in the medium
likely resulted from some unspecific reactions. Since the
decrease of uracil yield was always accompanied with a
remarkable increase of uridine yield, the uracil accumu-
lated in the medium was mainly derived from uridine or
UMP. Under the precondition of the pdp gene defi-
ciency, the amount of residual uracil in the medium
seems to be negatively correlated with the amount of the
available PRPP in the cell (TD12np). Hence, the unspe-
cific reactions which result in the residual uracil are
likely subject to the level of intercellular PRPP pool.
Conclusions
We deleted/overexpressed the genes which were closely
related to pyrimidine nucleoside biosynthesis by using
genetic manipulation method in B. subtilis168 and con-
structed a series of recombinant strains. The results of
shaking flask fermentation demonstrated that the de-
regulation of pyr operon, the overexpression of the prs,
pyrG and pyrH genes, and the deletion of the nupC-pdp
gene all facilitated the over-synthesis of pyrimidine nu-
cleoside compounds. The production of uridine and
cytidine were up to 1684.6 mg/L and 1423 mg/L in the
result strain TD33np, respectively. (i) The UMP synthe-
sis operon (pyr operon) and the PRPP synthesis
(encoded by the prs gene) are both rate-determining fac-
tors for the UMP biosynthesis. If the feedback inhibi-
tions of PRPP synthetase and carbamoyl phosphate
synthetaserelease are released, the production of pyrimi-
dine nucleoside compounds may be improved further.
(ii) The overexpression of the pyrH and pyrG genes can
improve the proportion of cytidine in the pyrimidine nu-
cleoside products, while reduce the proportion of uri-
dine. If the feedback inhibition of the CTP synthetase
and UMP kinase are released, the proportion of cytidine
in the pyrimidine nucleoside products may be improved
further. (iii) The pyrimidine nucleoside phosphorylase
(encoded by the pdp gene) activity is of close correlation
with the accumulation of uracil in the medium, and the
deletion of the nupC-pdp gene can reduce the
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medium. (iv) The cdd gene is a key factor of the accu-
mulation of cytidine, and if cytidine deaminase activity is
restored, the proportion of uridine in the accumulated
pyrimidine compounds will increase sharply.
Materials and methods
The bacterial strains and general culture conditions
The strains used in this study are listed in Table 2. All or-
ganisms were cultured in Luria-Bertani (LB) medium or
on 1.5% (w/v) agar plates supplemented with the appro-
priate antibiotics when required. Chloramphenicols (Cm),
6 μg ml−1and neomycin (Nm), 15 μg ml−1, were used to
select resistant B. subtilis cells. For liquid cultures, B. sub-
tilis were incubated at 37°C and were shaken at 220 rpm.
DNA manipulation techniques and PCR
The isolation and manipulation of DNA were conducted
according to standard procedures [29]. All chromosomal
DNA were extracted from B. subtilis and isolated by the
protocol of Sangon Biotech (Shanghai, China). PCR was
performed with DNA Ploymerase HiFi or Taq DNA
polymerase (TransGen, Beijing, China) in a DNA ther-
mal cycler (DNAEngine, BIO-RED, Hercules, CA, USA)
through the procedure recommended by the manufac-
turer. Overlapped extension PCR (SOE-PCR) was car-
ried out as decribed [30,31]. PCR products were purified
with a PCR Purification kit (Biomed, Beijing, China) and
analyzed by electrophoresis in 1% (w/v) agarose gels.
Transformation and transformants’ seletion
Transformation of B. subtilis was performed by using
competent cells as described by Anagnostopoulos and
Spizizen [32]. Competent transformation used liner
DNA frangments. The transformants seletion relied on
the method described by Liu et al. [33,34].Table 2 Strains
Strain Relevant genotype
B.subtilis 168 (BGSC 1A1) trpC2
B.subtilis 168 N trpC2, ΔaraR::neoR
B.subtilis TD01 trpC2, ΔaraR::neoR,Δcdd
B.subtilis TD02 trpC2, ΔaraR::neoR, Δcdd, Δhom
B.subtilis TD12 trpC2,ΔaraR::neoR, Δcdd, Δhom, Δp
B.subtilis TD12np trpC2,ΔaraR::neoR, Δcdd, Δhom, Δp
B.subtilis TD13 trpC2,ΔaraR::neoR, Δcdd, Δhom,Δpy
B.subtilis TD13np trpC2,ΔaraR::neoR, Δcdd, Δhom,Δp
B.subtilis TD231 trpC2,ΔaraR::neoR, Δcdd, Δhom, Δp
B.subtilis TD232 trpC2,ΔaraR::neoR, Δcdd, Δhom, Δp
B.subtilis TD33 trpC2,ΔaraR::neoR, Δcdd, Δhom, Δp
B.subtilis TD33np trpC2,ΔaraR::neoR, Δcdd, Δhom, Δp
pyrG+: the pyrG gene was constitutively expressed. pyrG+*: the pyrG gene was overeGene deletion
The method of marker-free gene deletion was as de-
scribed by Liu et al. [33,34]. We took pyrR gene as an
example. The fragment using for deleting the pyrR gene
was constructed as follows. The 0.9 kb cat (C) fragment
was amplified from the pC194 plasmid using the primers
Cat1qr and Cat2r (Table 3) [35]. The 1.2 kb araR (R)
fragment, including the whole coding region of the araR
gene, was amplified from the B. subtilis 168 genome
using the primers araR1qr and araR2qr. The 1.3 kb
UPpyrR (U), 0.9 kb DNpyrR (D) and 0.5 kb GpyrR (G)
fragments were amplified from the B. subtilis 168 gen-
ome using the primers pyrUP1 and pyrUP2, pyrDN1q
and pyrDN2, and pyrG1and pyrG2, respectively. These
five PCR fragments were then ligated in the order U-D-
C-R-G by splicing by overlapped extension PCR (SOE-
PCR) using the primers pyrUP1 and pyrG2 and then
were used to transform. The deletions of the cdd, hom
and nupC-pdp genes were similar to the pyrR gene.
Gene overexpression
To overexpress the pyrH gene, the inherent ITR of the
pyrH was replaced by a stronger promoter A1 of bac-
teriophage φ29 ligated to the mRNA stabilizer of the
aprE gene (PAE expression cassette) (Figure 6). To over-
express the prs gene, another prs gene copy controlling
by PAE expression cassette was integrated in chromo-
some the xylR gene locus. The method to overexpress
the pyrG gene is that a standardized promoter along
with the the gsiB mRNA stabilizer (PSB expression cas-
sette) was inserted after the inherent pyrG promoter
(Figure 4). The method to constitutively express the
pyrG gene is that 4 extra G residues at the 5′ ends of
the pyrG ITR. The method of marker-free gene modifi-
cation was derived from Liu et al. [33,34]. The specific






yrR, ΔnupC-pdp This study
rR, ΔxylR::prs This study
yrR, ΔxylR::prs, ΔnupC-pdp This study
yrR, ΔxylR::prs, pyrG+ This study
yrR,ΔxylR::prs, pyrG+* This study
yrR, ΔxylR::prs,pyrG+*,pyrH+ This study
yrR,ΔxylR::prs,pyrG+*,pyrH+, ΔnupC-pdp This study
xpressed.
Table 3 Primers and synthetized fragments
Oligonucleotides for pyrR gene deletion
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structed as follows. The 0.9 kb cat (C) fragment was
amplified from the pC194 plasmid using the primers
Cat1qh and Cat2h (Table 3). The 1.2 kb araR (R) frag-
ment was amplified from the B. subtilis 168 genome
using the primers araR1qh and araR2. The 1 kb UPpyrH
(U), 0.7 kb DNpyrH (D) and 0.6 kb GpyrH (G) frag-
ments were amplified from the B. subtilis 168 genome
using the primers pyrHUP1 and pyrHUP2q, pyrHDN1q
and pyrHDN2, and pyrHG1q and pyrHG2, respectively.
The 0.8 kb pyrH (H) fragment, including the whole cod-
ing region of the pyrH gene, was amplified from the B.
subtilis 168 genome using the primers pyrH1q and
pyrH2q. The 0.15 kb Promoter (P) fragment was whole
sequence synthesized by AuGCT DNA-SYN Biotechnol-
ogy Corporation (Beijing, China), including PAE expres-
sion cassette, and ligated to plasmid pGH-A0981Gn. P
fragment was amplified from plasmid pGH-A0981Gn by
using the primers p1h and p2h. These seven PCR frag-
ments were then ligated in the order G-R-C-D-H-P-U
by splicing by SOE-PCR using the primers pyrHUP1 and
pyrHG2 and then be used to transform. DNA sequen-
cing was done at AuGCT DNA-SYN BiotechnologyFigure 6 Nucleotide sequence of PAE expression cassette. The sequence o
promoter, transcription start site (+1), Shine–Dalgarno sequence (SD) and i
are shown in italics.Corporation (Beijing, China) by using primers CX1h and
CX2h. The constitutive expression and overexpression
of the pyrG gene, and the overexpressions of the prs
gene were similar to the pyrH gene.Fermentation
A loop of cells grown on an agar plate of LB medium
was inoculated into a 250 mL flask containing 30 mL of
stock culture medium (2% glucose, 2% soybean meal
hydrolysate, 1% yeast extract, 0.25% NaCl, 0.1%
MgSO4.7H2O, 0.1% KH2PO4, 0.5% sodiumglutamate,
pH = 7.0) and was then cultured for 16 h at 37°C, with
shaking at 220 rpm. 1.5 mL of the culture was trans-
ferred to a 250 mL flask containing 30 mL of fermenta-
tion medium (8% glucose, 3% soybean meal hydrolysate,
2% cornsteepliquor, 1.5% yeast extract, 0.25% NaCl, 0.8%
MgSO4.7H2O, 0.25% KH2PO4, 1.5% (NH4)2SO4, 1.5%
sodiumglutamate, pH = 7.0) and was then cultured for
72 h at 37°C, with shaking at 220 rpm. Samples were
drawn at various time-points during the fermentation
and were analyzed for cell growth (OD600) and pyrimi-
dine compounds content.f the nontemplate strand is shown. The −10 and −35 regions of the
nitiation codon are bold and underlined. The RNA-stabilizing elements
Zhu et al. Microbial Cell Factories  (2015) 14:54 Page 11 of 12Fermentation compounds analysis
The qualitative analysis of pyrimidine nucleoside and
pyrimidine compounds in the medium was conducted
by massspectrograph (Q-Exactive, Thermo Scientific,
Waltham, MA, USA).The quantitative analysis of
cytidine, uridine and uracil were conducted by HPLC
(Waters 2695, Waters, Milford, MA, USA) with an
HYPERSIL ODS C18 column (Thermo Scientific,
Waltham, MA, USA). Separation was performed at 40°C
with 0.05 M KH2PO4 at a flowrate of 1.5 mL min
−1.
The detective wavelength was 270 nm.Quantitative real-time reverse transcription (RT)-PCR analysis
Total RNA of B. subtilis was extracted with RNAprep
pure Cell/Bacteria Kit (TIANGEN, Beijing, China) as rec-
ommended by the supplier and was reverse-transcribed in
cDNA using the Maxima First Strand cDNA Synthesis Kit
(Thermo Scientific, Waltham, MA, USA) according to the
manufacturer’s instructions. The Real-time PCR was car-
ried out by LightCycler 480 (Roche Diagnostics GmbH,
Mannheim, Germany) using SYBR Green Ι Master (Roche
Diagnostics GmbH, Mannheim, Germany). The ccpA gene
was served as internal control of Real-time PCR. The
quantification cycle (Cq) was determined according to the
second derivative maximum method using the LightCycler
software 4.1 (Roche Diagnostics GmbH, Mannheim,
Germany). The relative expression ratio (RE) was calcu-
lated according to Pfaffl [36].Additional file
Additional file 1: The identification of the gene deletion. Figure S1
The identification of the cdd gene deletion. (A) Lane 1: marker. Lanes 2–7:
PCR products of the recombinants (lanes 2–6, 2004 bp) and the WT strain
(lane 7, 2155 bp) by using the primers cddUP1 and cddG2. (B) Lane 1:
marker. Lanes 2–7: PCR products of the recombinants (lanes 2–6, 512 bp,
604 bp and 888 bp) and the WT strain (lane 7, 512 bp, 604 bp and
1039 bp) digested by SacI and EcoRI. Figure S2 The identification of the
hom gene deletion. Lane 1: marker. Lanes 2, 4: PCR products of the WT
strain (lane 2, 2531 bp) and the recombinant (lane 4, 1700 bp) by using
the primers homUP1 and homDN2. Lanes 3, 5: PCR products of the WT
strain (lane 3, 619 bp and 1912 bp) and the recombinant (lane 5, 619 bp
and 1081 bp) digested by SphI. Figure S3 The identification of the pyrR
gene deletion. Lane 1: marker. Lanes 2, 4: PCR products of the WT strain
(lane 2, 2642 bp) and the recombinant (lane 4, 1904 bp) by using the
primers pyrUP1 and pyrDN2. Lanes 3, 5: PCR products of the WT strain
(lane 3, 531 bp and 2111 bp) and the recombinant (lane 5, 531 bp and
1373 bp) digested by PstI. Figure S4 The identification of the nupC-pdp
gene deletion. Lane 1: marker. Lanes 2, 5: PCR products of the WT strain
(lane 2, 3433 bp) and the recombinant (lane 5, 1495 bp) by using the
primers pnUP1 and pnDN2. Lanes 3, 6: PCR products of the WT strain
(lane 3, 474 bp and 2959 bp) and the recombinant (lane 6, 474 bp and
1021 bp) digested by HindIII. Lanes 4, 7: PCR products of the WT strain
(lane 4, 174 bp, 339 bp, 1452 bp and 1468 bp) and the recombinant
(lane 7, 174 bp, 339 bp and 982 bp) digested by EcoRV.Competing interests
The authors declare that they have no competing interests.Authors’ contributions
HZ designed the experiments; HZ, ZMY and SMY performed the experiments;
HZ and RB wrote the manuscript; RB supervised the work; and all authors
contributed to the discussion of the research. All authors read and approved
the final manuscript.
Acknowledgements
We gratefully acknowledge the generous support of Lei Guo and Dr. Xi-xian
Xie from Tianjin University of Science and Technology in fermentation
experiments. We also appreciate Thermo Fisher Scientific for its important
contributions (Shanghai, China) to qualitative analyses of fermentation
products with Mass Spectrometry.
Received: 20 November 2014 Accepted: 31 March 2015
References
1. Turner RJ, Bonner ER, Grabner GK. Purification and characterization of
bacillus subtilis PyrR, a bifunctional pyr mRNA-binding attenuation protein/
uracil phosphoribosyl transferase. J Biol Chem. 1998;273(10):5932–8.
2. Quinn CL, Stephenson BT, Switer RL. Functional organization and nucleotide
sequence of the Bacillus subtilis pyrimidine biosynthetic operon. J Biol
Chem. 1991;266:9113–27.
3. Turner RJ, Lu Y, Switzer RL. Regulation of the Bacillus subtilis pyrimidine
biosynthetic (pyr) gene cluster by an atogenous transcriptional attenuation
mechanism. J Bacterol. 1994;76(12):3708–22.
4. Hobl B, Mack M. The regulator protein PyrR of Bacillus subtilis specifically
interacts in vivo with three untranslated regions within pyr mRNA of
pyrimidine biosynthesis. Microbiology. 2007;153(3):693–700.
5. Parsot C, Cohen GN. Cloning and nucleotide sequence of the Bacillus subtilis
hom gene coding for homoserine dehydrogense. Structural and
evolutionary relationships with Escherichia coli aspartokinases–homoserine
dehydrogenases I and II. J Biol Chem. 1988;263:14654–60.
6. Hilden I, Krath BN, Hove-jensen B. Tricistronic operon expression of the
genes gcaD (tms), which encodes N-acetylglucosamine 1-phosphate uridyl-
transferase, prs, which encodes phosphoribosyl diphosphate synthetase, and
ctc in vegetative cells of Bacillus subtilis. J Bacteriol. 1995;177(24):7280–4.
7. Shimaoka M, Takenaka Y, Kurahashi O, Kawasaki H, Matsui H. Effect of
amplification of desensitized purF and prs on inosine accumulation in
Escherichia coli. J Biosci Bioeng. 2007;103(3):255–61.
8. Zakataeva NP, Romanenkov DV, Skripnikova VS, Vitushkina MV, Livshits VA,
Kivero AD, et al. Wild-type and feedback-resistant phosphoribosyl
pyrophosphate synthetases from Bacillus amyloliquefaciens: purification,
characterization, and application to increase purine nucleoside production.
Appl Microbiol Biotechnol. 2012;93:2023–33.
9. Gagyi C, Ionescu M, Gounon P, Sakamoto H, Rousslle JC, Laurent-Winter C.
Identification and immunochemical location of UMP kinase from Bacillus
subtilis. Curr Microbiol. 2004;48:62–7.
10. Serina L, Blondin C, Krin E, Sismeiro O, Danchin A, Sakamoto H, et al.
Escherichia coli UMP-kinase, a member of the aspartokinase family, is a
hexamer regulated by guanine nucleotides and UTP. J Biol Chem.
1995;34:5066–74.
11. Meng Q, Turnbough CL, Switzer RL. Attenuation control of pyrG expression
in Bacillus subtilis is mediated by CTP-sensitive reiterative transcription.
Proc Natl Acad Sci. 2004;101:10943–8.
12. Meng Q, Turnbough CL, Switzer RL. Regulation of pyrG expression in Bacillus
subtilis: CTP-regulated antitermination and reiterative transcription with pyrG
templates in vitro. Mol Microbiol. 2007;63(5):1440–52.
13. Elsholz AKW, Jogenson CM, Switzer RL. The number of G residues in the
Bacillus subtilis pyrG initially transcribed region governs reiterative
transcription-mediated regulation. J Bacteriol. 2007;189(5):2176–80.
14. Song B-H, Jan N. Chromosomal location, cloning and nucleotide sequence
of the Bacillus subtilis cdd gene encoding cytidine/deoxycytidine deaminase.
Mol Gen Genet. 1989;216:462–8.
15. Saxild HH, Andersen LN, Hammer K. Dra-nupC-pdp operon of Bacillus subtilis:
nucleotide sequence, induction by deoxyribonucleosides, and
transcriptional regulation by the deoR-encoded DeoR repressor protein.
J Bacteriol. 1996;178:424–34.
16. Zeng X, Saxild HH. Identication and characterization of a DeoR specic
operator sequence essential for induction of the dra-nupC-pdp operon
expression in Bacillus subtilis. J Bacteriol. 1999;181:1719–27.
Zhu et al. Microbial Cell Factories  (2015) 14:54 Page 12 of 1217. Zeng X, Saxild HH, Switzer RL. Purication and characterization of the DeoR
repressor of Bacillus subtilis. J Bacteriol. 2000;182:1916–22.
18. Asahi S, Tsunemi Y, Lzawa M, Doi M. Cytidine production by Mutants of
Bacillus subtilis. Biosci Biotech Biochem. 1994;58(8):1399–402.
19. Asahi S, Tsunemi Y, Lzawa M, Doi M. A 3-deazauracil-resistant mutant of
Bacillus subtilis with increased production of cytidine. Biosci Biotech
Biochem. 1994;59(5):915–6.
20. Asahi S, Tsunemi Y, Doi M. Improvement of a cytidine-producing mutant of
Bacillus subtilis introducing a mutantion by homologous recombination.
Biosci Biotech Biochem. 1995;59(11):2123–6.
21. Doi M, Asahi S, Tsunemi Y, Akiyama S. Mechanism of uridine production by
Bacillus subtilis mutants. Appl Microbiol Biotechnol. 1989;30:234–8.
22. Su J, Huang J, Xie XX, Xu QY, Chen N. Knockout of the cdd gene in Bacillus
subtilis and its influence on cytidine fermentation. Lett Biotechnol.
2010;21(1):39–42.
23. Paulus TJ, McGarry TJ, Shekelle PG, Rosenzweig S, Switzer RL. Coordinate
synthesis of the enzymes of pyrimidine biosynthesis in Bacillus subtilis.
J Bacteriol. 1982;149:775–8.
24. Potvin BW, Kelleher RJ. Pyrimidine biosynthetic pathway of Bacillus subtilis.
J Bacteriol. 1975;123:604–15.
25. Asahara T, Mori Y, Zakataeva NP, Livshits VA, Yoshida K, Matsuno K.
Accumulation of gene-targeted Bacillus subtilis mutationsthat enhance
fermentative inosine production. Appl Microbiol Biotechnol.
2010;87:2195–207.
26. Switzer RL, Sogin DC. Regulation and mechanism of phosphoribosyl
pyrophosphate synthetase. V. Inhibition by end products and regulation by
adenine diphosphate. J Biol Chem. 1973;248:1063–73.
27. Martinussen J, Glaser P, Andersen PS, Saxild HH. Two genes encoding uracil
phosphoribosyltransferase are present in Bacillus subtilis. J Bacteriol.
1995;177(1):271–4.
28. Neuhard J. In: Munch-Petersen, editor. Utilization of preformed pyrimidine
bases and nucleosides: Metabolism of nucleotides, nucleosides and
nucleobases in microorganisms. London: Academic Press; 1983. p. 95–148.
29. Sambrook J, Russell D. Molecular cloning: a laboratory manual. 3rd ed.
Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2001.
30. Kuwayama H, Obara S, Morio T, Katoh M, Urushihara H, Tanaka Y.
PCR-mediated generation of a gene disruption construct without the
use of DNA ligase and plasmid vectors. Nucleic Acids Res. 2002;30(2):e2.
31. Shevchuk NA, Bryksin AV, Nusinovich YA, Cabello FC, Sutherland M, Ladisch S.
Construction of long DNA molecules using long PCR-based fusion of
several fragments simultaneously. Nucleic Acids Res. 2004;32(2):e19.
32. Anagnostopoulos C, Spizizen J. Requirements for transformation in Bacillus
subtilis. J Bacteriol. 1961;81(5):741–6.
33. Liu S, Endo K, Ara K, Ozaki K, Naotake O. Introduction of marker-free
deletions in Bacillus subtilis using the AraR repressor and the ara promoter.
Microbiology. 2008;154(9):2562–70.
34. Dong HN, Zhang DW. Current development in genetic engineering
strategies of Bacillus species. Microb Cell Fact. 2014;13:63.
35. Horinouchi S, Weisblum B. Nucleotide sequence and functional map of
pC194, a plasmid that specifies inducible chloramphenicol resistance.
J Bacteriol. 1982;150(2):815–25.
36. Pfaffl MV. A new mathematical model for relative quantification in real-time
RT-PCR. Nucleic Acids Res. 2001;29(9):e45.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
